Agilex Biolabs, Australia's largest most technologically advanced regulated bioanalytical and toxicology laboratory provides reliable and defendable bioanalytical, biomarker, and toxicology data, enabling our clients globally to improve human health. For almost 25 years, we are recognised for our scale and proven track record for large and small molecule bioanalysis, including quality method development, method validation and sample analysis services.
Our world-class immunoassay and immunobiology laboratories feature state-of-the-art equipment, including Gyrolab xPlore, MSD Quickplex 120, Luminex Magpix, BD FACSymphony A3 flow cytometer and the digital droplet quantitative real-time analysis for RNA, siRNA, and miRNA clinical trials, including vaccines and gene therapy trials. Furthermore, Agilex Biolabs has ISO/IEC17025 accreditation and OECD GLP recognition with NATA to ensure the highest quality standards are met for seamless end to end testing for pre-clinical to clinical analysis.
Agilex Biolabs also offers a range of toxicology services to support preclinical through to early/late-phase clinical programs through our established GLP facility located in Brisbane, Australia. These services include exploratory toxicology and pharmacokinetics studies, and GLP toxicology services. We have expertise with all types of molecules, laboratory species, routes of administration, and non-clinical studies.
As a global leader in providing flexible solutions, Agilex Biolabs has accelerated numerous biopharmaceutical and pharmaceutical drug development programs from USA, APAC, and Europe. We would like to engage biotech and pharma companies interested in utilising Australia as their early phase clinical trial location to access regulatory speed, R&D Tax cash-back incentives and premium quality service.